Howland Capital Management Lowered Its Merck & Co (MRK) Position; Sterling Construction Co (STRL)’s Sentiment Is 1.92

November 15, 2017 - By Clifton Ray

Howland Capital Management Llc decreased Merck & Co Inc (MRK) stake by 11.39% reported in 2017Q2 SEC filing. Howland Capital Management Llc sold 5,575 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Howland Capital Management Llc holds 43,382 shares with $2.78 million value, down from 48,957 last quarter. Merck & Co Inc now has $149.98B valuation. The stock declined 0.44% or $0.24 reaching $54.75 per share. About 72,236 shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since November 15, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.

Sterling Construction Company, Inc. is a heavy civil construction firm engaged in the building and reconstruction of transportation and water infrastructure projects in Texas, Utah, Nevada, Arizona, California, Hawaii and other states. The company has market cap of $449.86 million. The Company’s transportation infrastructure projects include highways, roads, bridges, airfields, ports and light rail. It has a 4458.44 P/E ratio. The Company’s water infrastructure projects include water, wastewater and storm drainage systems.

Among 22 analysts covering Merck & Co. Inc. (NYSE:MRK), 14 have Buy rating, 0 Sell and 8 Hold. Therefore 64% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $66.59’s average target is 21.63% above currents $54.75 stock price. Merck & Co. Inc. had 67 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Hold” rating by SunTrust given on Monday, October 30. BMO Capital Markets maintained the shares of MRK in report on Tuesday, July 4 with “Sell” rating. The company was maintained on Friday, September 8 by Credit Suisse. As per Thursday, October 13, the company rating was upgraded by Bank of America. Citigroup upgraded Merck & Co., Inc. (NYSE:MRK) on Wednesday, October 18 to “Buy” rating. UBS maintained the stock with “Buy” rating in Monday, July 31 report. Jefferies upgraded Merck & Co., Inc. (NYSE:MRK) on Tuesday, October 31 to “Hold” rating. The company was maintained on Monday, July 17 by Deutsche Bank. The stock of Merck & Co., Inc. (NYSE:MRK) has “Equal-Weight” rating given on Monday, October 30 by Barclays Capital. The company was maintained on Friday, November 3 by Cowen & Co.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on February, 1. They expect $0.94 EPS, up 5.62% or $0.05 from last year’s $0.89 per share. MRK’s profit will be $2.57 billion for 14.56 P/E if the $0.94 EPS becomes a reality. After $1.11 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -15.32% negative EPS growth.

Howland Capital Management Llc increased Vanguard Intl Equity Index F (VGK) stake by 11,345 shares to 443,218 valued at $24.44 million in 2017Q2. It also upped Celgene Corp (NASDAQ:CELG) stake by 6,682 shares and now owns 144,398 shares. Vanguard Bd Index Fd Inc (BSV) was raised too.

Investors sentiment increased to 1.07 in Q2 2017. Its up 0.08, from 0.99 in 2017Q1. It is positive, as 56 investors sold MRK shares while 612 reduced holdings. 111 funds opened positions while 603 raised stakes. 1.95 billion shares or 0.77% less from 1.96 billion shares in 2017Q1 were reported. Monroe Bancorporation And Trust Mi has invested 0.03% in Merck & Co., Inc. (NYSE:MRK). Systematic Mngmt Limited Partnership stated it has 118,114 shares. Private Ocean reported 0.07% in Merck & Co., Inc. (NYSE:MRK). Bridgeway Capital holds 0.16% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 209,135 shares. Braun Stacey Associates stated it has 315,596 shares. Moreover, Tower Bridge Advisors has 0% invested in Merck & Co., Inc. (NYSE:MRK) for 118,306 shares. 20,707 are held by Family Capital Com. Gilman Hill Asset Mngmt Ltd Liability holds 0.3% or 10,836 shares in its portfolio. Btr reported 1.27% stake. Lucas Capital holds 7,874 shares. Professional Advisory Services Incorporated reported 7,372 shares. Bath Savings reported 5,427 shares stake. Winfield Associates owns 0.04% invested in Merck & Co., Inc. (NYSE:MRK) for 1,002 shares. Hancock Company holds 0.07% or 24,668 shares in its portfolio. Cayman Islands-based Quantres Asset Limited has invested 0.23% in Merck & Co., Inc. (NYSE:MRK).

It closed at $16.63 lastly. It is down 121.51% since November 15, 2016 and is uptrending. It has outperformed by 104.81% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :